Search results for the GEO ID: GSE5389
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM123243
GPL96
brain_OFC_bipolar B_mr212 human post-mortem brain tissue, bipolar disorder Disease_status: Bipolar disorder Age (years): 31 Gender: Male Age of onset (years): 21 Duration of illness (years): 10 Brain pH: 6.3 Post mortem interval (hours): 28 Side of brain: Right Fluphenazine mg. Equivalents: 30000 Lithium treatment: No Valproate treatment: No Electroconvulsive therapy: No Suicide: Yes Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 5 Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 6 none
GSM123244
GPL96
brain_OFC_bipolar B_mr221 human post-mortem brain tissue, bipolar disorder Disease_status: Bipolar disorder Age (years): 50 Gender: Female Age of onset (years): 25 Duration of illness (years): 25 Brain pH: 6.3 Post mortem interval (hours): 62 Side of brain: Left Fluphenazine mg. Equivalents: 0 Lithium treatment: No Valproate treatment: Yes Electroconvulsive therapy: No Suicide: No Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0 Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0 none
GSM123245
GPL96
brain_OFC_bipolar B_mr233 human post-mortem brain tissue, bipolar disorder Disease_status: Bipolar disorder Age (years): 50 Gender: Male Age of onset (years): 17 Duration of illness (years): 23 Brain pH: 6.2 Post mortem interval (hours): 19 Side of brain: Left Fluphenazine mg. Equivalents: 60000 Lithium treatment: No Valproate treatment: Yes Electroconvulsive therapy: No Suicide: Yes Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0 Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1 none
GSM123246
GPL96
brain_OFC_bipolar B_mr351 human post-mortem brain tissue, bipolar disorder Disease_status: Bipolar disorder Age (years): 48 Gender: Female Age of onset (years): 16 Duration of illness (years): 32 Brain pH: 5.8 Post mortem interval (hours): 22 Side of brain: Left Fluphenazine mg. Equivalents: 32000 Lithium treatment: No Valproate treatment: Yes Electroconvulsive therapy: No Suicide: No Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 3 Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 5 none
GSM123247
GPL96
brain_OFC_bipolar B_mr384 human post-mortem brain tissue, bipolar disorder Disease_status: Bipolar disorder Age (years): 61 Gender: Female Age of onset (years): 18 Duration of illness (years): 43 Brain pH: 6.5 Post mortem interval (hours): 60 Side of brain: Left Fluphenazine mg. Equivalents: 40000 Lithium treatment: Yes Valproate treatment: No Electroconvulsive therapy: Yes (5 treatments) Suicide: Yes Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0 Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1 none
GSM123248
GPL96
brain_OFC_bipolar B_mr421 human post-mortem brain tissue, bipolar disorder Disease_status: Bipolar disorder Age (years): 30 Gender: Male Age of onset (years): 22 Duration of illness (years): 8 Brain pH: 6.1 Post mortem interval (hours): 31 Side of brain: Right Fluphenazine mg. Equivalents: 60000 Lithium treatment: Yes Valproate treatment: No Electroconvulsive therapy: No Suicide: No Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0 Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3 none
GSM123249
GPL96
brain_OFC_bipolar B_mr89 human post-mortem brain tissue, bipolar disorder Disease_status: Bipolar disorder Age (years): 48 Gender: Male Age of onset (years): 27 Duration of illness (years): 21 Brain pH: 6.1 Post mortem interval (hours): 13 Side of brain: Right Fluphenazine mg. Equivalents: 200 Lithium treatment: No Valproate treatment: No Electroconvulsive therapy: No Suicide: Yes Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 3 Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2 none
GSM123250
GPL96
brain_OFC_bipolar B_mr91 human post-mortem brain tissue, bipolar disorder Disease_status: Bipolar disorder Age (years): 37 Gender: Female Age of onset (years): 14 Duration of illness (years): 23 Brain pH: 6.5 Post mortem interval (hours): 29 Side of brain: Right Fluphenazine mg. Equivalents: 1200 Lithium treatment: Yes Valproate treatment: No Electroconvulsive therapy: Yes Suicide: Yes Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 4 Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 6 none
GSM123251
GPL96
brain_OFC_bipolar B_mr93 human post-mortem brain tissue, bipolar disorder Disease_status: Bipolar disorder Age (years): 50 Gender: Female Age of onset (years): 34 Duration of illness (years): 16 Brain pH: 6.1 Post mortem interval (hours): 18 Side of brain: Left Fluphenazine mg. Equivalents: 12000 Lithium treatment: No Valproate treatment: No Electroconvulsive therapy: No Suicide: No Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 5 Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3 none
GSM123252
GPL96
brain_OFC_bipolar B_mr94 human post-mortem brain tissue, bipolar disorder Disease_status: Bipolar disorder Age (years): 30 Gender: Male Age of onset (years): 7 Duration of illness (years): 23 Brain pH: 5.8 Post mortem interval (hours): 56 Side of brain: Right Fluphenazine mg. Equivalents: 0 Lithium treatment: No Valproate treatment: No Electroconvulsive therapy: No Suicide: Yes Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0 Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1 none
GSM123253
GPL96
brain_OFC_control C_mr131 human post-mortem brain tissue, healthy control Disease_status: Healthy control Age (years): 52 Gender: Male Age of onset (years): N/A Duration of illness (years): N/A Brain pH: 6.5 Post mortem interval (hours): 8 Side of brain: Left Fluphenazine mg. Equivalents: N/A Lithium treatment: N/A Valproate treatment: N/A Electroconvulsive therapy: N/A Suicide: No Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0 Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1 none
GSM123254
GPL96
brain_OFC_control C_mr169 human post-mortem brain tissue, healthy control Disease_status: Healthy control Age (years): 53 Gender: Male Age of onset (years): N/A Duration of illness (years): N/A Brain pH: 6.2 Post mortem interval (hours): 28 Side of brain: Left Fluphenazine mg. Equivalents: N/A Lithium treatment: N/A Valproate treatment: N/A Electroconvulsive therapy: N/A Suicide: No Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 2 Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2 none
GSM123255
GPL96
brain_OFC_control C_mr170 human post-mortem brain tissue, healthy control Disease_status: Healthy control Age (years): 52 Gender: Male Age of onset (years): N/A Duration of illness (years): N/A Brain pH: 6.2 Post mortem interval (hours): 22 Side of brain: Right Fluphenazine mg. Equivalents: N/A Lithium treatment: N/A Valproate treatment: N/A Electroconvulsive therapy: N/A Suicide: No Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0 Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3 none
GSM123256
GPL96
brain_OFC_control C_mr202 human post-mortem brain tissue, healthy control Disease_status: Healthy control Age (years): 58 Gender: Male Age of onset (years): N/A Duration of illness (years): N/A Brain pH: 6.0 Post mortem interval (hours): 27 Side of brain: Left Fluphenazine mg. Equivalents: N/A Lithium treatment: N/A Valproate treatment: N/A Electroconvulsive therapy: N/A Suicide: No Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0 Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1 none
GSM123257
GPL96
brain_OFC_control C_mr206 human post-mortem brain tissue, healthy control Disease_status: Healthy control Age (years): 52 Gender: Male Age of onset (years): N/A Duration of illness (years): N/A Brain pH: 6.5 Post mortem interval (hours): 28 Side of brain: Left Fluphenazine mg. Equivalents: N/A Lithium treatment: N/A Valproate treatment: N/A Electroconvulsive therapy: N/A Suicide: No Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0 Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2 none
GSM123258
GPL96
brain_OFC_control C_mr216 human post-mortem brain tissue, healthy control Disease_status: Healthy control Age (years): 44 Gender: Female Age of onset (years): N/A Duration of illness (years): N/A Brain pH: 6.3 Post mortem interval (hours): 25 Side of brain: Right Fluphenazine mg. Equivalents: N/A Lithium treatment: N/A Valproate treatment: N/A Electroconvulsive therapy: N/A Suicide: No Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0 Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1 none
GSM123259
GPL96
brain_OFC_control C_mr217 human post-mortem brain tissue, healthy control Disease_status: Healthy control Age (years): 35 Gender: Female Age of onset (years): N/A Duration of illness (years): N/A Brain pH: 6.6 Post mortem interval (hours): 23 Side of brain: Right Fluphenazine mg. Equivalents: N/A Lithium treatment: N/A Valproate treatment: N/A Electroconvulsive therapy: N/A Suicide: No Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 1 Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0 none
GSM123260
GPL96
brain_OFC_control C_mr231 human post-mortem brain tissue, healthy control Disease_status: Healthy control Age (years): 68 Gender: Female Age of onset (years): N/A Duration of illness (years): N/A Brain pH: 6.3 Post mortem interval (hours): 13 Side of brain: Left Fluphenazine mg. Equivalents: N/A Lithium treatment: N/A Valproate treatment: N/A Electroconvulsive therapy: N/A Suicide: No Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0 Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0 none
GSM123261
GPL96
brain_OFC_control C_mr350 human post-mortem brain tissue, healthy control Disease_status: Healthy control Age (years): 41 Gender: Male Age of onset (years): N/A Duration of illness (years): N/A Brain pH: 6.0 Post mortem interval (hours): 11 Side of brain: Right Fluphenazine mg. Equivalents: N/A Lithium treatment: N/A Valproate treatment: N/A Electroconvulsive therapy: N/A Suicide: No Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0 Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1 none
GSM123262
GPL96
brain_OFC_control C_mr381 human post-mortem brain tissue, healthy control Disease_status: Healthy control Age (years): 42 Gender: Male Age of onset (years): N/A Duration of illness (years): N/A Brain pH: 6.6 Post mortem interval (hours): 27 Side of brain: Right Fluphenazine mg. Equivalents: N/A Lithium treatment: N/A Valproate treatment: N/A Electroconvulsive therapy: N/A Suicide: No Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0 Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0 none
GSM123263
GPL96
brain_OFC_control C_mr96 human post-mortem brain tissue, healthy control Disease_status: Healthy control Age (years): 29 Gender: Female Age of onset (years): N/A Duration of illness (years): N/A Brain pH: 6.2 Post mortem interval (hours): 42 Side of brain: Left Fluphenazine mg. Equivalents: N/A Lithium treatment: N/A Valproate treatment: N/A Electroconvulsive therapy: N/A Suicide: No Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0 Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0 none
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes